Agency
Granville-Vance District Health Department
Granville-Vance District Health Department was paid $4.94M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 59% of everything it billed.
33Billing provider infoGRANVILLE-VANCE DISTRICT HEALTH DEPARTMENT
OXFORD, NC 27565
OXFORD, NC 27565
33aNPI1184783409assigned 12/06/2006
33bProvider typeCase Management Agency
28Total paid$4.94M
24GClaims638,239
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Management Agency providers in North Carolina
Rank by total paid#54 of 195
Median peer was paid$2.05M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,576 | $223K | |
| 2019 | 10,413 | $278K | |
| 2020 | 6,397 | $239K | |
| 2021 | 75,398 | $695K | |
| 2022 | 164,913 | $1.08M | |
| 2023 | 176,249 | $1.15M | |
| 2024incomplete | 197,293 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 59% | 558,248 | 496,119 | $2.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 5,215 | 3,692 | $476K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.9% | 3,759 | 2,756 | $240K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1.9% | 2,217 | 1,907 | $93K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 1.7% | 897 | 450 | $84K |
| D1120 | Dental cleaning, childProphylaxis - child | 1.6% | 2,885 | 2,549 | $78K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 1.4% | 2,511 | 2,237 | $68K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 5,468 | 4,147 | $63K |
| D1110 | Prophylaxis - adult | 1.2% | 1,580 | 1,416 | $59K |
| T1002 | Rn services, up to 15 minutes | 1.2% | 1,602 | 940 | $59K |
| D0220 | Intraoral - periapical first radiographic image | 1.2% | 4,020 | 3,445 | $59K |
| D1206 | Topical application of fluoride varnish | 1.2% | 3,642 | 3,224 | $59K |
90 more codes
| D0330 | Panoramic radiographic image | 1.2% | 1,104 | $58K |
| 99502 | 1.1% | 1,297 | $55K | |
| 99501 | <1% | 1,332 | $45K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,999 | $43K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,624 | $43K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 3,232 | $40K |
| D0274 | Bitewings - four radiographic images | <1% | 1,280 | $39K |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,072 | $37K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 247 | $28K |
| D1351 | Sealant - per tooth | <1% | 1,415 | $23K |
| 0001A | <1% | 346 | $17K | |
| 96127 | <1% | 3,832 | $17K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,647 | $17K |
| 0002A | <1% | 359 | $16K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 173 | $16K |
| D4355 | <1% | 258 | $15K | |
| D0272 | Bitewings - two radiographic images | <1% | 839 | $13K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,601 | $11K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 153 | $11K |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 210 | $10K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 152 | $9K |
| 87210 | <1% | 1,832 | $8K | |
| 90688 | <1% | 1,288 | $8K | |
| 0071A | <1% | 150 | $6K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,306 | $5K |
| 80305 | <1% | 509 | $5K | |
| 0072A | <1% | 113 | $5K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 58 | $4K |
| 0064A | <1% | 88 | $4K | |
| 99406 | <1% | 320 | $4K | |
| 0134A | <1% | 711 | $4K | |
| 82120 | <1% | 1,412 | $3K | |
| 85018 | <1% | 1,501 | $3K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 205 | $3K |
| 0012A | <1% | 49 | $3K | |
| 90480 | <1% | 111 | $3K | |
| 90715 | <1% | 386 | $3K | |
| 86803 | <1% | 308 | $3K | |
| 90651 | <1% | 108 | $3K | |
| 81025 | <1% | 567 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 23 | $3K |
| 0124A | <1% | 425 | $3K | |
| 0011A | <1% | 45 | $2K | |
| 0004A | <1% | 51 | $2K | |
| 0054A | <1% | 96 | $2K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 24 | $2K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 52 | $2K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 13 | $2K |
| 99383 | <1% | 22 | $2K | |
| 91320 | <1% | 39 | $1K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 41 | $1K |
| 81002 | <1% | 571 | $1K | |
| 90734 | <1% | 498 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 51 | $985.32 |
| 90658 | <1% | 181 | $848.65 | |
| 99401 | <1% | 55 | $820.55 | |
| 96160 | <1% | 431 | $752.37 | |
| 91322 | <1% | 40 | $584.20 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 238 | $499.82 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 159 | $428.34 |
| 90686 | <1% | 1,273 | $347.17 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 127 | $312.74 |
| 87340 | <1% | 26 | $201.11 | |
| 90670 | <1% | 71 | $190.91 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $149.36 |
| 82950 | <1% | 67 | $144.96 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 44 | $132.16 |
| 96161 | <1% | 60 | $131.64 | |
| 86592 | <1% | 163 | $76.04 | |
| 92587 | <1% | 84 | $30.08 | |
| 91300 | <1% | 140 | $28.07 | |
| 99173 | <1% | 120 | $24.81 | |
| 91307 | <1% | 275 | $8.19 | |
| 91305 | 0% | 165 | $0.00 | |
| D3120 | 0% | 83 | $0.00 | |
| 3074F | 0% | 42 | $0.00 | |
| 90656 | 0% | 93 | $0.00 | |
| 90677 | 0% | 32 | $0.00 | |
| 3079F | 0% | 37 | $0.00 | |
| 90647 | 0% | 70 | $0.00 | |
| 90723 | 0% | 22 | $0.00 | |
| 0500F | 0% | 22 | $0.00 | |
| 91306 | 0% | 15 | $0.00 | |
| 91301 | 0% | 30 | $0.00 | |
| 99072 | 0% | 611 | $0.00 | |
| 91313 | 0% | 709 | $0.00 | |
| 90633 | 0% | 49 | $0.00 | |
| 90710 | 0% | 60 | $0.00 | |
| 90700 | 0% | 14 | $0.00 | |
| 91312 | 0% | 426 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUTHRIE, SHAUNA (HEALTH DIRECTOR)